Diagnosis of osteoporosis and assessment of fracture risk.

By J. Kanis. The Lancet, 2002

2,334 citations recorded by the source corpus.

Subfields: Oncology, Orthopedics and Sports Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/8c02f7cbbe05432b54e7bfb44f2df75bbdb7fd23

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. J. Kanis
2. O. Johnell
3. H. Johansson
4. Eugene V. McCloskey
5. A. Odén
6. J. Reginster
7. Chris Cooper
8. N. Burlet

In Orthopedics and Sports Medicine

1. J. Kanis
2. Chris Cooper
3. Eugene V. McCloskey
4. H. Johansson
5. J. Reginster
6. R. Rizzoli
7. O. Johnell
8. A. Odén

In Surgery

1. J. Kanis
2. Eugene V. McCloskey
3. Chris Cooper
4. J. Reginster
5. O. Johnell
6. H. Johansson
7. R. Rizzoli
8. A. Odén

Citations in the corpus

• Alcohol intake as a risk factor for fracture (2005, background): “Since alcohol intake confers a risk over and above that provided by age and BMD, intervention thresholds for BMD can be less stringent [47].”
• FRAX™ and the assessment of fracture probability in men and women from the UK (2008, background): “For this reason, there has been interest in the development of algorithms that express absolute risk, or the probability of fracture within a given time period [18–20], as has been done for cardiovascular and other diseases [21– 25].”
• American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. (2003, background): “5 standard deviations (expressed as a t-score) below peak bone mass or the mean bone density for young white adult women.(30) Osteopenia, or low bone mass, is defined as a t-score of 1 to 2.”
• Predictive Value of BMD for Hip and Other Fractures (2005, background): “Because the decrease in predictive ability was rather small, it will not markedly affect the computation of 10-year fracture probability that has been proposed as an index of risk in assessment.((14,51))”
• European guidance for the diagnosis and management of osteoporosis in postmenopausal women (2018, background): “For the purposes of improving risk assessment, interest lies in those factors that contribute significantly to fracture risk over and above that provided by bonemineral density measurements or age [56].”
• Grip Strength across the Life Course: Normative Data from Twelve British Studies (2014, neutral): “The life course trajectory identified for grip strength in our study is similar to the well-established life course trajectory of bone mineral density (BMD) [30].”
• A Meta‐Analysis of Prior Corticosteroid Use and Fracture Risk (2004, background): “5 SD at the femoral neck.((27)) Because exposure to corticosteroids confers a risk over and above that provided by BMD, intervention threshTABLE 4.”
• FRAX and its applications to clinical practice. (2009, background): “Since the development of such guidelines, it has become apparent that the presence of several of the risk factors used to trigger a BMD test is associated with a fracture risk greater than can be accounted for by BMD alone [14].”
• European guidance for the diagnosis and management of osteoporosis in postmenopausal women (2008, background): “For the purposes of improving risk assessment, interest lies in those factors that contribute significantly to fracture risk over and above that provided by bone mineral density measurements or age [58].”
• The Female Athlete Triad (2007, neutral): “7 No BMD threshold discriminates perfectly between those who will and will not experience a fracture (95).”
• Smoking and fracture risk: a meta-analysis (2005, background): “Attention has focused recently on assessing fracture probability by using multiple risk factors, rather than BMD alone, to provide intervention thresholds [8, 14, 15].”
• Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK (2008, background): “Since the development of the RCP guidelines, it has become apparent that the presence of several of the risk factors used to trigger a BMD test is associated with a fracture risk greater than can be accounted for by BMD alone [7].”
• A meta-analysis of previous fracture and subsequent fracture risk. (2004, background): “These include smoking, corticosteroid exposure, a family history of fracture, secondary osteoporosis [39], and possibly the biochemical indices of bone turnover [63].”
• The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women (2007, neutral): “Their consideration along with BMD in the assessment of fracture risk increases the sensitivity of the test without sacrificing specificity [9].”
• Assessment of fracture risk (2005, background): “How can the combined intelligence of the presence or absence of risk factors, BMD and age be factored into estimates of fracture probability? The general Table 5 Risks for osteoporotic fractures [27]”
• Osteoporosis: a still increasing prevalence. (2005, background): “it is currently recommended that postmenopausal women, with the highest risk, should be screened for osteoporosis and a 10-year probability of fracture assessed for each individual to determine intervention thresholds [11].”